- Home
- EVOK vs CING Comparison
EVOK vs CING Comparison
Compare EVOK & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- CING
- Stock Information
- Founded
- EVOK 2007
- CING 2012
- Country
- EVOK United States
- CING United States
- Employees
- EVOK N/A
- CING N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- EVOK Health Care
- CING Health Care
- Exchange
- EVOK Nasdaq
- CING Nasdaq
- Market Cap
- EVOK 18.4M
- CING 21.6M
- IPO Year
- EVOK 2013
- CING 2021
- Fundamental
- Price
- EVOK $10.85
- CING $3.69
- Analyst Decision
- EVOK
- CING Strong Buy
- Analyst Count
- EVOK 0
- CING 3
- Target Price
- EVOK N/A
- CING $32.67
- AVG Volume (30 Days)
- EVOK 246.8K
- CING 137.4K
- Earning Date
- EVOK 11-13-2025
- CING 11-13-2025
- Dividend Yield
- EVOK N/A
- CING N/A
- EPS Growth
- EVOK N/A
- CING N/A
- EPS
- EVOK N/A
- CING N/A
- Revenue
- EVOK $14,424,652.00
- CING N/A
- Revenue This Year
- EVOK $57.38
- CING N/A
- Revenue Next Year
- EVOK $59.57
- CING N/A
- P/E Ratio
- EVOK N/A
- CING N/A
- Revenue Growth
- EVOK 67.40
- CING N/A
- 52 Week Low
- EVOK $1.94
- CING $3.20
- 52 Week High
- EVOK $10.86
- CING $6.01
- Technical
- Relative Strength Index (RSI)
- EVOK 84.40
- CING 51.78
- Support Level
- EVOK $10.66
- CING $3.41
- Resistance Level
- EVOK $10.75
- CING $3.69
- Average True Range (ATR)
- EVOK 0.06
- CING 0.23
- MACD
- EVOK -0.08
- CING 0.02
- Stochastic Oscillator
- EVOK 78.26
- CING 75.38
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.